Second-moment Designation From National Cancer Institute Received By MCG

January 02nd, 2008 | Category: Cancer

The Medical College of Georgia has again been designated by the National Cancer Institute as a Minority-Based Community Clinical Oncology Program.The renewal, which comes with a five-year $2.3 million grant, provides more access to the latest cancer treatment and prevention strategies for

all cancer patients, particularly minorities, says Dr. Anand Jillella, chief of the MCG section of Hematology/Oncology and principal investigator on the grant. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
  • Proteolix’s Carfilzomib Receives Orphan Drug Designation For Treatment Of Multiple Myeloma
  • EpiVax Receives 600,000 Dollars Grant To Develop Treatment For Diabetes From National Institutes Of Health
  • Epeius Biotechnologies’ Tumor Targeted Rexin G Receives FDA Orphan Drug Designation For The Treatment Of Osteosarcoma
  • Celldex Therapeutics Receives Fast-Track Designation For CDX-110, A Novel EGFRvIII Vaccine For Glioblastoma

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.